Use of the NADH-Quinone Oxidoreductase (NDI1) Gene ofSaccharomyces cerevisiae as a Possible Cure for Complex I Defects in Human Cells
Open Access
- 1 December 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (48), 37774-37778
- https://doi.org/10.1074/jbc.m007033200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Mitochondrial gene therapy: an arena for the biomedical use of inteinsTrends in Biotechnology, 2000
- The NDUFA1 gene product (MWFE protein) is essential for activity of complex I in mammalian mitochondriaProceedings of the National Academy of Sciences, 1999
- NADH:ubiquinone oxidoreductase from bovine heart mitochondria: sequence of a novel 17.2‐kDa subunitFEBS Letters, 1998
- Procaryotic complex I (NDH-1), an overviewBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1998
- Human complex I defects in neurodegenerative diseasesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1998
- Human Complex I deficiency: Clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defectBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1998
- Oxidative Phosphorylation Diseases and Mitochondrial DNA Mutations: Diagnosis and TreatmentAnnual Review of Nutrition, 1994
- URF6, Last Unidentified Reading Frame of Human mtDNA, Codes for an NADH Dehydrogenase SubunitScience, 1986
- THE MITOCHONDRIAL ELECTRON TRANSPORT AND OXIDATIVE PHOSPHORYLATION SYSTEMAnnual Review of Biochemistry, 1985
- Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory-chain NADH dehydrogenaseNature, 1985